Colorado’s 2025 legislative session kicked off on Wednesday, January 8th, and will continue for 120 days until May 7th. Key issues that are top of mind for the Colorado life sciences ecosystem include preserving funding for the Advanced Industries Accelerator Grant Programs run by Colorado’s Office of Economic Development and International Trade and ensuring the federal 340B Drug Pricing Program is benefiting the patients it was intended to help. CBSA has been educating legislators and briefing media organizations about these important issues.
Recent news coverage highlighting CBSA’s concerns around these topics includes:
- Denver Business Journal, 1/10/25: “Trade group sounds alarm over potential cuts to Colorado business grants”
- Denver Business Journal, 12/23/24: “Colorado’s pharma, hospital industries prepare for fight over drug discounts”
